drugset / Trial / NCT04187053
Clinical and Microbiologic Outcomes of aPDT in the Non-surgical Treatment of Implant Inflammation
Phase 4
Completed
56 enrolled
The University of Texas Health Science Center, Houston
Academy of Laser Dentistry · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to compare clinical outcomes (change in bleeding sites (BOP) and probing depth reduction (PPD) after mechanical debridement of implant surfaces at sites exhibiting plaque induced inflammation with or without adjunctive antimicrobial photodynamic therapy (aPDT) and assess the microbiologic profile of plaque samples before and after treatment with or without aPDT samples.
Timeline
- Start
- 2020-02-14
- Primary completion
- 2022-12-06
- Completion
- 2022-12-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methylene Blue | Diagnostic / imaging agent | 0.1 mg/ml | Topical |
Indications
No indication recorded.